Adição na publicação
#15.35
10/13/2021
RPI 2649
Application data
Number
112019015788Type
Filing
Publication
PCT
US2018016664 The application was abandoned: examination was not requested within the 36 months following the 02/02/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/13/2021. We update with every new RPI gazette, published weekly.
Applicants
ANTIDOTE THERAPEUTICS, INC.
US
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
US
Inventors
C. R. (pessoa física)
US
E. S. (pessoa física)
US
M. K. (pessoa física)
US
M. R. (pessoa física)
US
T. T. (pessoa física)
US
IPC Classification
Priority claims
US
62/454,331 · 02/03/2017
US
62/535,507 · 07/21/2017
Abstract
Trata-se de variantes de enzima de degradação de nicotina que exibem atividade de degradação de nicotina aumentada e/ou imunogenicidade diminuída em relação às enzimas NicA2 e NOX do tipo selvagem, composições que compreendem as variantes e métodos de uso das mesmas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/13/2021
RPI 2649
#11.1.1
08/03/2021
RPI 2639
#11.1
05/18/2021
RPI 2628
#1.3
03/17/2020
RPI 2567
#1.1
08/13/2019
RPI 2536
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.